When did King Pharmaceuticals report Q2 2025 earnings?

King Pharmaceuticals (KG) reported Q2 2025 earnings on August 15, 2025 before market open.

What were King Pharmaceuticals's Q2 2025 revenue and EPS?

King Pharmaceuticals reported revenue of $546.0K and diluted EPS of $-0.72 for Q2 2025.

Where can I find King Pharmaceuticals's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0002055116-25-000018) directly on SEC EDGAR. The filing index links above go to sec.gov.

King Pharmaceuticals KG Q2 2025 earnings

Reported August 15, 2025 · Before market open

Revenue$546.0K Diluted EPS-$0.72

Next report

Aug 7, 2026 (In 3 weeks)

Revenue estimate$338.6M

Financials

Q2 2025

Income statement

See full

Revenue$5.6M+780%

Net income$69.9M+12,884%

EPS (diluted)$15.05+7,625%

Balance sheet

See full

Cash & equivalents$33.7M+575%

Total debt$175.9M—

Total equity$150.1M+2,955%

Total assets$1.2B—

Cash flow

See full

Operating cash flow-$19.9M—

Valuation & ratios

Valuation

as of 06/30/25

See full

Market cap$248.69M—

Enterprise value$390.96M—

P/S29.7×—

Returns & leverage

See full

Debt / equity1.2×—

Versus estimates

Revenue

Q1 2026$10.2MMiss by $336.3M Q4 2025$10.2MMiss by $412.5M Q3 2025$20.3M

Q2 2025$546.0K

Diluted EPS

Q1 2026-$1.34 Q4 2025-$1.06Miss by $2.26 Q3 2025-$1.95

Q2 2025-$0.72

Ask the moment King Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did King Pharmaceuticals report Q2 2025 earnings?: King Pharmaceuticals (KG) reported Q2 2025 earnings on August 15, 2025 before market open.
What were King Pharmaceuticals's Q2 2025 revenue and EPS?: King Pharmaceuticals reported revenue of $546.0K and diluted EPS of $-0.72 for Q2 2025.
Where can I find King Pharmaceuticals's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0002055116-25-000018) directly on SEC EDGAR. The filing index links above go to sec.gov.